Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Kirkpatrick

Showing results (181-190 of 219) with videos related to

Pageof 22
Sort By:
International Journal of Radiation Oncology, Biology, Physics|December 30, 2020
Stereotactic Radiosurgery for Vestibular Schwannomas: Tumor Control Probability Analyses and Recommended Reporting StandardsScott G Soltys, Michael T Milano, Jinyu Xue, et al.
Neuro-Oncology Advances|July 10, 2020
Performance of a nomogram for IDH-wild-type glioblastoma patient survival in an elderly cohortErica Shen, Margaret O Johnson, Jessica W Lee, et al.
CNS Oncology|September 21, 2021
Primary brain tumor patients admitted to a US intensive care unit: a descriptive analysisJennifer H Kang, Christa B Swisher, Evan D Buckley, et al.
Journal of Radiosurgery and SBRT|January 31, 2020
Predicting intracranial progression following stereotactic radiosurgery for brain metastases: Implications for post SRS imagingBrahma D Natarajan, Christel N Rushing, Michael A Cummings, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2011
The addition of bevacizumab to standard radiation therapy and temozolomide followed by bevacizumab, temozolomide, and irinotecan for newly diagnosed glioblastomaJames J Vredenburgh, Annick Desjardins, David A Reardon, et al.
Advances in Radiation Oncology|February 27, 2023
Outcomes in Patients with Intact and Resected Brain Metastasis Treated with 5-Fraction Stereotactic RadiosurgeryDavid J Carpenter, Andrew T Fairchild, Justus D Adamson, et al.
Advances in Radiation Oncology|May 1, 2024
Determinants of Symptomatic Intracranial Progression After an Initial Stereotactic Radiosurgery CourseJim X Leng, David J Carpenter, Christina Huang, et al.
Cancer|January 24, 2020
Current multidisciplinary management of brain metastasesMichael J Moravan, Peter E Fecci, Carey K Anders, et al.
Practical Radiation Oncology|May 24, 2016
Radiation therapy for glioblastoma: Executive summary of an American Society for Radiation Oncology Evidence-Based Clinical Practice GuidelineAlvin R Cabrera, John P Kirkpatrick, John B Fiveash, et al.
International Journal of Radiation Oncology, Biology, Physics|June 4, 2013
Concurrent stereotactic radiosurgery and bevacizumab in recurrent malignant gliomas: a prospective trialAlvin R Cabrera, Kyle C Cuneo, Annick Desjardins, et al.
Pageof 22

Showing results (181-190 of 219) with videos related to

Sort By:
Pageof 22
International Journal of Radiation Oncology, Biology, Physics|December 30, 2020
Stereotactic Radiosurgery for Vestibular Schwannomas: Tumor Control Probability Analyses and Recommended Reporting StandardsScott G Soltys, Michael T Milano, Jinyu Xue, et al.
Neuro-Oncology Advances|July 10, 2020
Performance of a nomogram for IDH-wild-type glioblastoma patient survival in an elderly cohortErica Shen, Margaret O Johnson, Jessica W Lee, et al.
CNS Oncology|September 21, 2021
Primary brain tumor patients admitted to a US intensive care unit: a descriptive analysisJennifer H Kang, Christa B Swisher, Evan D Buckley, et al.
Journal of Radiosurgery and SBRT|January 31, 2020
Predicting intracranial progression following stereotactic radiosurgery for brain metastases: Implications for post SRS imagingBrahma D Natarajan, Christel N Rushing, Michael A Cummings, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2011
The addition of bevacizumab to standard radiation therapy and temozolomide followed by bevacizumab, temozolomide, and irinotecan for newly diagnosed glioblastomaJames J Vredenburgh, Annick Desjardins, David A Reardon, et al.
Advances in Radiation Oncology|February 27, 2023
Outcomes in Patients with Intact and Resected Brain Metastasis Treated with 5-Fraction Stereotactic RadiosurgeryDavid J Carpenter, Andrew T Fairchild, Justus D Adamson, et al.
Advances in Radiation Oncology|May 1, 2024
Determinants of Symptomatic Intracranial Progression After an Initial Stereotactic Radiosurgery CourseJim X Leng, David J Carpenter, Christina Huang, et al.
Cancer|January 24, 2020
Current multidisciplinary management of brain metastasesMichael J Moravan, Peter E Fecci, Carey K Anders, et al.
Practical Radiation Oncology|May 24, 2016
Radiation therapy for glioblastoma: Executive summary of an American Society for Radiation Oncology Evidence-Based Clinical Practice GuidelineAlvin R Cabrera, John P Kirkpatrick, John B Fiveash, et al.
International Journal of Radiation Oncology, Biology, Physics|June 4, 2013
Concurrent stereotactic radiosurgery and bevacizumab in recurrent malignant gliomas: a prospective trialAlvin R Cabrera, Kyle C Cuneo, Annick Desjardins, et al.
Pageof 22